Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
AbbVie
Emma Guttman-Yassky; Henrique D Teixeira; Eric L Simpson; Kim A Papp; Aileen L Pangan; Andrew Blauvelt; Diamant Thaçi; Chia-Yu Chu; H Chih-Ho Hong; Norito Katoh; Amy S Paller; Brian Calimlim; Yihua Gu; Xiaofei Hu; Meng Liu; Yang Yang; John Liu; Allan R Tenorio; Alvina D Chu; Alan D Irvine